CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 DiaMedica Therapeutics Inc. - DMAC CFD

1.5750
1.89%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.1100
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 1.5458
开盘价* 1.545
1 年变化* -44.42%
日范围* 1.545 - 1.575
52 周范围 1.12-3.06
平均交易量(10 天) 26.19K
平均交易量(3 个月) 827.55K
市值 45.48M
市盈率 -100.00K
流通股 26.44M
收入 N/A
EPS -0.50
股息(收益率 %) N/A
贝塔 1.76
下一个财报发布日期 Mar 28, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 22, 2023 1.5458 -0.0479 -3.01% 1.5937 1.6633 1.5454
Mar 21, 2023 1.6729 -0.0391 -2.28% 1.7120 1.7122 1.5843
Mar 20, 2023 1.6925 -0.0382 -2.21% 1.7307 1.7314 1.6529
Mar 17, 2023 1.7316 -0.0188 -1.07% 1.7504 1.7505 1.7010
Mar 16, 2023 1.8296 0.0891 5.12% 1.7405 1.8394 1.7405
Mar 15, 2023 1.6923 -0.0383 -2.21% 1.7306 1.7416 1.6820
Mar 14, 2023 1.7805 0.0878 5.19% 1.6927 1.8297 1.6422
Mar 13, 2023 1.6922 0.1276 8.16% 1.5646 1.7221 1.5646
Mar 10, 2023 1.6531 -0.0182 -1.09% 1.6713 1.7019 1.5645
Mar 9, 2023 1.6923 0.0502 3.06% 1.6421 1.7707 1.6421
Mar 8, 2023 1.7709 0.0994 5.95% 1.6715 1.7906 1.6715
Mar 7, 2023 1.7219 0.0798 4.86% 1.6421 1.7221 1.6421
Mar 6, 2023 1.7020 -0.0188 -1.09% 1.7208 1.7612 1.6723
Mar 3, 2023 1.7316 0.0790 4.78% 1.6526 1.7514 1.6526
Mar 2, 2023 1.7414 0.0300 1.75% 1.7114 1.7612 1.7114
Mar 1, 2023 1.7315 -0.0294 -1.67% 1.7609 1.7609 1.6428
Feb 28, 2023 1.6923 0.0502 3.06% 1.6421 1.7416 1.6421
Feb 27, 2023 1.6535 0.0099 0.60% 1.6436 1.7024 1.5842
Feb 24, 2023 1.6729 0.0297 1.81% 1.6432 1.6828 1.6333
Feb 23, 2023 1.6925 -0.0089 -0.52% 1.7014 1.7604 1.6822

DiaMedica Therapeutics Inc. Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018 2017
总收入 0 0 0 0.5 0
总营业费用 13.646 12.699 11.593 7.261 4.519
销售/一般/行政费用,总计 4.881 4.389 3.693 2.739 1.313
研究与开发 8.765 8.31 7.9 4.522 3.206
Depreciation / Amortization
营业收入 -13.646 -12.699 -11.593 -6.761 -4.519
利息收入(费用),非经营净值 0 -0.039 0.009
其他,净值 0.082 0.434 0.975 1.146 0.25
税前净收入 -13.564 -12.265 -10.618 -5.654 -4.26
税后净收入 -13.592 -12.292 -10.649 -5.734 -4.26
未计算非常项目前的净收益 -13.592 -12.292 -10.649 -5.734 -4.26
净收入 -13.592 -12.292 -10.649 -5.734 -4.26
普通股股东可获收益 (不含非经常性项目) -13.592 -12.292 -10.649 -5.734 -4.26
普通股股东可获收益 (含非經常性項目) -13.592 -12.292 -10.649 -5.734 -4.26
摊薄净收入 -13.592 -12.292 -10.649 -5.734 -4.26
摊薄后加权平均股 20.7734 15.6803 11.9877 7.74352 5.93579
扣除特别项目的每股摊薄盈利 -0.6543 -0.78391 -0.88833 -0.74049 -0.71768
每股正常摊薄盈利 -0.6543 -0.78391 -0.88833 -0.74049 -0.71768
收入 0 0.5 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 0 0 0 0 0
总营业费用 3.536 3.246 3.416 3.365 3.619
销售/一般/行政费用,总计 1.562 1.375 1.084 1.209 1.213
研究与开发 1.974 1.871 2.332 2.156 2.406
营业收入 -3.536 -3.246 -3.416 -3.365 -3.619
其他,净值 0.035 0.007 -0.027 0.098 0.004
税前净收入 -3.501 -3.239 -3.443 -3.267 -3.615
税后净收入 -3.508 -3.246 -3.45 -3.274 -3.622
未计算非常项目前的净收益 -3.508 -3.246 -3.45 -3.274 -3.622
净收入 -3.508 -3.246 -3.45 -3.274 -3.622
普通股股东可获收益 (不含非经常性项目) -3.508 -3.246 -3.45 -3.274 -3.622
普通股股东可获收益 (含非經常性項目) -3.508 -3.246 -3.45 -3.274 -3.622
摊薄净收入 -3.508 -3.246 -3.45 -3.274 -3.622
摊薄后加权平均股 26.4431 26.5021 19.0357 18.7862 18.7667
扣除特别项目的每股摊薄盈利 -0.13266 -0.12248 -0.18124 -0.17428 -0.193
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.13266 -0.12248 -0.18124 -0.17428 -0.193
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 45.439 27.921 8.836 17.972 1.494
现金和短期投资 45.112 27.507 7.878 16.823 1.353
Cash 4.707 7.409 3.883 16.823 1.353
应收账款总额,净额 0.13 0.34 0.823 0.78 0.08
Prepaid Expenses 0.084 0.064 0.047 0.369 0.061
Total Assets 45.551 28.095 9.053 18.339 1.802
Property/Plant/Equipment, Total - Net 0.112 0.174 0.217 0.096 0.037
Property/Plant/Equipment, Total - Gross 0.179 0.231 0.26
Accumulated Depreciation, Total -0.067 -0.057 -0.043
Total Current Liabilities 1.524 2.028 1.318 1.296 1.003
Accounts Payable 0.509 1.099 0.182
Accrued Expenses 1.011 0.923 1.13
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 0.084
Total Liabilities 1.527 2.081 1.436 1.314 1.003
Total Long Term Debt 0.003 0.007 0.013 0.018 0
Other Liabilities, Total 0 0.046 0.105
Total Equity 44.024 26.014 7.617 17.025 0.799
Common Stock 0 0 0 0 0
Additional Paid-In Capital 126.576 94.925 64.232 62.993 41.033
Retained Earnings (Accumulated Deficit) -82.501 -68.909 -56.617 -45.968 -40.234
Other Equity, Total -0.051 -0.002 0.002
Total Liabilities & Shareholders’ Equity 45.551 28.095 9.053 18.339 1.802
Total Common Shares Outstanding 26.4431 18.7462 12.0069 11.9569 6.37066
Accounts Receivable - Trade, Net 0.13 0.78 0.08
Other Long Term Assets, Total 0 0.271 0.271
Payable/Accrued 1.291 0.919
Current Port. of LT Debt/Capital Leases 0.004 0.006 0.006 0.005 0
Capital Lease Obligations 0.003 0.007 0.013 0.018 0
短期投资 40.405 20.098 3.995
Other Current Assets, Total 0.113 0.01 0.088
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 42.111 45.439 48.537 21.629 24.195
现金和短期投资 41.047 45.112 48.097 21.295 23.401
Cash 3.032 4.707 16.219 2.228 3.329
短期投资 38.015 40.405 31.878 19.067 20.072
应收账款总额,净额 0.168 0.13 0.104 0.016 0.337
Prepaid Expenses 0.793 0.084 0.336 0.318 0.457
Total Assets 42.211 45.551 48.664 21.774 24.356
Property/Plant/Equipment, Total - Net 0.1 0.112 0.127 0.145 0.161
Property/Plant/Equipment, Total - Gross 0.162 0.179 0.187 0.199 0.209
Accumulated Depreciation, Total -0.062 -0.067 -0.06 -0.054 -0.048
Total Current Liabilities 1.434 1.524 1.624 1.44 1.178
Accounts Payable 0.433 0.509 0.699 0.239 0.689
Accrued Expenses 0.995 1.011 0.921 1.196 0.483
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.006 0.004 0.004 0.005 0.006
Total Liabilities 1.443 1.527 1.628 1.456 1.211
Total Long Term Debt 0.009 0.003 0.004 0.005 0.005
Capital Lease Obligations 0.009 0.003 0.004 0.005 0.005
Other Liabilities, Total 0 0 0.011 0.028
Total Equity 40.768 44.024 47.036 20.318 23.145
Common Stock 0 0 0 0 0
Additional Paid-In Capital 126.884 126.576 126.296 96.126 95.68
Retained Earnings (Accumulated Deficit) -86.009 -82.501 -79.255 -75.805 -72.531
Other Equity, Total -0.107 -0.051 -0.005 -0.003 -0.004
Total Liabilities & Shareholders’ Equity 42.211 45.551 48.664 21.774 24.356
Total Common Shares Outstanding 26.4431 26.4431 26.4392 18.7862 18.7862
Accounts Receivable - Trade, Net 0.166 0.13
Other Current Assets, Total 0.103 0.113
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -13.592 -12.292 -10.649 -5.734 -4.26
经营活动产生的现金 -12.252 -9.185 -9.102 -5.696 -3.9
经营活动产生的现金 0.024 0.021 0.021 0.015 0.004
非现金物品 1.777 1.891 1.139 0.659 0.4
已付现金利息 0.002 0.002
营运资金的变化 -0.461 1.195 0.387 -0.636 -0.044
投资活动产生的现金 -20.537 -16.134 -3.908 -0.05 -0.022
资本支出 -0.022 -0.047 -0.002 -0.05 -0.022
融资活动产生的现金 30.087 28.845 0.07 21.216 3.539
股票的发行(报废),净额 30.093 28.85 0.075 21.216 3.539
外汇效应
现金净变化 -2.702 3.526 -12.94 15.47 -0.383
Cash Taxes Paid 0.028 0.036 0.026
其他投资现金流量项目,总计 -20.515 -16.087 -3.906
债务的发行(退还),净额 -0.006 -0.005 -0.005
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -3.508 -13.592 -10.346 -6.896 -3.622
Cash From Operating Activities -3.888 -12.252 -9.448 -6.402 -4.313
Cash From Operating Activities 0.006 0.024 0.018 0.012 0.006
Non-Cash Items 0.443 1.777 1.354 1.023 0.551
Changes in Working Capital -0.829 -0.461 -0.474 -0.541 -1.248
Cash From Investing Activities 2.214 -20.537 -11.848 0.98 -0.009
Capital Expenditures 0 -0.022 -0.015 -0.013 -0.009
Other Investing Cash Flow Items, Total 2.214 -20.515 -11.833 0.993 0
Cash From Financing Activities -0.001 30.087 30.106 0.241 0.242
Issuance (Retirement) of Stock, Net 0 30.093 30.111 0.244 0.244
Issuance (Retirement) of Debt, Net -0.001 -0.006 -0.005 -0.003 -0.002
Net Change in Cash -1.675 -2.702 8.81 -5.181 -4.08
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
EQT Partners AB Private Equity 10.8 2855847 304827 2022-07-08 LOW
Trill AB,LLC. Corporation 9.6472 2551020 2551020 2021-09-28
Jacinto (Richard II) Individual Investor 9.4543 2500000 850947 2022-12-31 LOW
Lytton (Laurence W) Individual Investor 4.0539 1071970 -308296 2021-12-31 MED
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.961 782989 349 2022-12-31 LOW
Giuffre (Randall Michael) Individual Investor 1.4983 396184 35130 2023-01-03 LOW
Omega Advisors, Inc. Investment Advisor 1.1345 300000 100000 2021-12-31 LOW
Jacob Asset Management of New York, LLC Investment Advisor 0.8839 233730 -4770 2022-12-31 LOW
Pilnik (Richard D) Individual Investor 0.7937 209882 55555 2023-01-03 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6991 184870 -349 2022-12-31 LOW
Lynch (Timothy Patrick) Individual Investor 0.3792 100259 -100000 2022-12-31 LOW
Burroughs (Amy Louise) Individual Investor 0.2772 73288 17156 2023-01-03 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.2723 72012 2814 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.252 66629 0 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.2496 65997 1067 2022-12-31 LOW
Pauls (Dietrich John) Individual Investor 0.211 55804 20000 2022-11-16
Morgan Stanley & Co. LLC Research Firm 0.1672 44201 2194 2022-12-31 MED
Alcorn Harry W Jr Individual Investor 0.1663 43981 399 2022-03-22 MED
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.1612 42634 0 2022-12-31 LOW
Citadel Advisors LLC Hedge Fund 0.1483 39216 4304 2022-12-31 HIGH

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

DiaMedica Therapeutics Inc. Company profile

关于 DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc.是一家处于临床阶段的生物制药公司。 公司专注于开发神经系统和肾脏疾病的治疗方法,如急性缺血性中风(AIS)和慢性肾脏疾病(CKD)。 公司的主导产品DM199模拟天然存在的人类KLK1蛋白的行为,以保护和恢复中风受损组织的血液循环,并改善整体肾功能。 KLK1是一种丝氨酸蛋白酶或蛋白质,主要产生于肾脏、胰腺和唾液腺。 DM199疗法有可能改善循环和关键系统的整体功能,以及减少炎症和氧化压力。 该公司还有其他针对IgA肾病和非裔美国人慢性肾病的产品管道。

Industry: Bio Therapeutic Drugs

301 Carlson Parkway
Suite 210
MINNEAPOLIS
MINNESOTA 55305
US

收入报表

  • Annual
  • Quarterly

人们也观看

Gold

1,981.86 Price
+0.550% 1D Chg, %
多头隔夜费 -0.0086%
空头隔夜费 0.0004%
隔夜费时间 21:00 (UTC)
价差 0.30

Oil - Crude

71.43 Price
+2.160% 1D Chg, %
多头隔夜费 -0.0170%
空头隔夜费 -0.0050%
隔夜费时间 21:00 (UTC)
价差 0.03

BTC/USD

27,500.00 Price
+0.320% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

XRP/USD

0.44 Price
+3.290% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00445

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易